Gastrointestinal mucormycosis, a rare fatal fungal infection in an immunocompromised host, affects mainly the stomach. Colonic mucormycosis is infrequent and is associated with high mortality. Perianal involvement is seen in almost one-third of patients with Crohn's disease. Perianal Crohn's disease is a particularly debilitating form of the disease, which requires multidisciplinary care. It may also require profound immunosuppression with biological agents to control disease activity. Opportunistic infections can complicate the disease course in these patients. We present a case of a middle-aged female with perianal Crohn's disease on adalimumab who developed colonic mucormycosis causing a flare in her disease activity. This patient highlights the need to increase awareness about fungal infections as a cause of disease flare in inflammatory bowel disease.
Keyphrases
- disease activity
- rheumatoid arthritis
- systemic lupus erythematosus
- rheumatoid arthritis patients
- healthcare
- middle aged
- ankylosing spondylitis
- intensive care unit
- palliative care
- juvenile idiopathic arthritis
- type diabetes
- cardiovascular disease
- newly diagnosed
- ejection fraction
- cardiovascular events
- case report
- chronic pain
- health insurance
- chronic kidney disease
- prognostic factors
- acute respiratory distress syndrome
- cell wall